Portfolio

Nature of Business

Amaxa, based in Cologne, Germany is an international market leader in high-end applications for the non-viral delivery of genes and the transfer of substrates into cells. 3i made an investment in the second round in 2001 and in 2002, Amaxa took its first steps in the US, establishing its operations in Maryland. Amaxa's technologies enhance the speed and quality of basic and pharmaceutical research in academia and industry. These gene transfer tools are the basis for clinical applications and for novel therapies in gene-based medicine